Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 42  Show

Literature citations Results

Whole genome sequencing of meticillin-resistant Staphylococcus aureus.

Kuroda M., Ohta T., Uchiyama I., Baba T., Yuzawa H., Kobayashi I., Cui L., Oguchi A., Aoki K., Nagai Y. et al.

Lancet 357:1225-1240(2001) · UniProtKB (5,315)

The PDZ protein tax-interacting protein-1 inhibits beta-catenin transcriptional activity and growth of colorectal cancer cells.

Kanamori M., Sandy P., Marzinotto S., Benetti R., Kai C., Hayashizaki Y., Schneider C., Suzuki H.

J. Biol. Chem. 278:38758-38764(2003) · UniProtKB (2) · Mapped (97)

The expression status of CD133 is associated with the pattern and timing of primary glioblastoma recurrence.

Shibahara I., Sonoda Y., Saito R., Kanamori M., Yamashita Y., Kumabe T., Watanabe M., Suzuki H., Watanabe T., Ishioka C. et al.

Neuro-oncology 15:1151-1159(2013) · Mapped (6)

The complete amino acid sequence of a major trypsin inhibitor from seeds of foxtail millet (Setaria italica).

Tashiro M., Asao T., Hirata C., Takahashi K., Kanamori M.

J. Biochem. 108:669-672(1990) · UniProtKB (1)

The association of lumbar disc disease with vitamin-D receptor gene polymorphism.

Kawaguchi Y., Kanamori M., Ishihara H., Ohmori K., Matsui H., Kimura T.

J Bone Joint Surg Am 84:2022-2028(2002) · Mapped (94)

T2BP, a novel TRAF2 binding protein, can activate NF-kappaB and AP-1 without TNF stimulation.

Kanamori M., Suzuki H., Saito R., Muramatsu M., Hayashizaki Y.

Biochem. Biophys. Res. Commun. 290:1108-1113(2002) · UniProtKB (1) · Mapped (8)

Suppressors of cytokine signaling: Potential immune checkpoint molecules for cancer immunotherapy.

Chikuma S., Kanamori M., Mise-Omata S., Yoshimura A.

Cancer Sci. 108:574-580(2017) · Mapped (7)

Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.

Okada M., Kanamori M., Someya K., Nakatsukasa H., Yoshimura A.

Epigenetics Chromatin 10:24-24(2017) · Mapped (3)

Role of scavenger receptors as damage-associated molecular pattern receptors in Toll-like receptor activation.

Komai K., Shichita T., Ito M., Kanamori M., Chikuma S., Yoshimura A.

Int. Immunol. 29:59-70(2017) · Mapped (21)

Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy.

Intracranial Germ Cell Tumor Genome Analysis Consortium
Ichimura K., Fukushima S., Totoki Y., Matsushita Y., Otsuka A., Tomiyama A., Niwa T., Takami H., Nakamura T., Suzuki T. et al.

Acta Neuropathol. 131:889-901(2016) · Mapped (5)

Physical and functional interaction between WRNIP1 and RAD18.

Yoshimura A., Seki M., Kanamori M., Tateishi S., Tsurimoto T., Tada S., Enomoto T.

Genes Genet. Syst. 84:171-178(2009) · Mapped (5)

PDGF receptor beta is a potent regulator of mesenchymal stromal cell function.

Tokunaga A., Oya T., Ishii Y., Motomura H., Nakamura C., Ishizawa S., Fujimori T., Nabeshima Y., Umezawa A., Kanamori M. et al.

J. Bone Miner. Res. 23:1519-1528(2008) · Mapped (6)

O(6)-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma.

Sonoda Y., Yokosawa M., Saito R., Kanamori M., Yamashita Y., Kumabe T., Watanabe M., Tominaga T.

Int. J. Clin. Oncol. 15:352-358(2010) · Mapped (7)

Novel mating type-dependent transcripts at the mating type locus in Magnaporthe oryzae.

Kanamori M., Kato H., Yasuda N., Koizumi S., Peever T.L., Kamakura T., Teraoka T., Arie T.

Gene 403:6-17(2007) · UniProtKB (12)

NF-kappaB activator Act1 associates with IL-1/Toll pathway adaptor molecule TRAF6.

Kanamori M., Kai C., Hayashizaki Y., Suzuki H.

FEBS Lett. 532:241-246(2002) · UniProtKB (2) · Mapped (7)

Negative regulation of EphA2 receptor by Cbl.

Wang Y.j., Ota S., Kataoka H., Kanamori M., Li Z.y., Band H., Tanaka M., Sugimura H.

Biochem. Biophys. Res. Commun. 296:214-220(2002) · Mapped (5)

Myxoid liposarcoma-associated EWSR1-DDIT3 selectively represses osteoblastic and chondrocytic transcription in multipotent mesenchymal cells.

Suzuki K., Matsui Y., Higashimoto M., Kawaguchi Y., Seki S., Motomura H., Hori T., Yahara Y., Kanamori M., Kimura T.

PLoS ONE 7:e36682-e36682(2012) · Mapped (7)

Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomas.

Intracranial Germ Cell Tumor Genome Analysis Consortium (iGCT Consortium)
Fukushima S., Otsuka A., Suzuki T., Yanagisawa T., Mishima K., Mukasa A., Saito N., Kumabe T., Kanamori M., Tominaga T. et al.

Acta Neuropathol. 127:911-925(2014) · Mapped (12)

Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects.

Nishigori H., Tomura H., Tonooka N., Kanamori M., Yamada S., Sho K., Inoue I., Kikuchi N., Onigata K., Kojima I. et al.

Proc. Natl. Acad. Sci. U.S.A. 98:575-580(2001) · UniProtKB (1)

Mutation in the pleckstrin homology domain of the human phospholipase C-delta 1 gene is associated with loss of function.

Shimohama S., Kamiya S., Fujii M., Ogawa T., Kanamori M., Kawamata J., Imura T., Taniguchi T., Yagisawa H.

Biochem. Biophys. Res. Commun. 245:722-728(1998)

Multivariate analysis of genetic and acquired factors; T235 variant of the angiotensinogen gene is a potent independent risk factor for preeclampsia.

Kobashi G., Shido K., Hata A., Yamada H., Kato E.H., Kanamori M., Fujimoto S., Kondo K.

Semin. Thromb. Hemost. 27:143-147(2001) · Mapped (14)

Molecular and morphological discrimination between an invasive ascidian, Ascidiella aspersa, and its congener A. scabra (Urochordata: Ascidiacea).

Nishikawa T., Oohara I., Saitoh K., Shigenobu Y., Hasegawa N., Kanamori M., Baba K., Turon X., Bishop J.D.

Zool. Sci. 31:180-185(2014) · UniProtKB (7)

Malignant clinical features of anaplastic gliomas without IDH mutation.

Shibahara I., Sonoda Y., Shoji T., Kanamori M., Saito R., Inoue T., Kawaguchi T., Yamashita Y., Watanabe T., Kumabe T. et al.

Neuro-oncology 17:136-144(2015) · Mapped (10)

Long-term survivors of glioblastoma: clinical features and molecular analysis.

Sonoda Y., Kumabe T., Watanabe M., Nakazato Y., Inoue T., Kanamori M., Tominaga T.

Acta Neurochir (Wien) 151:1349-1358(2009) · Mapped (196)

KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.

Sekiguchi J., Morita K., Kitao T., Watanabe N., Okazaki M., Miyoshi-Akiyama T., Kanamori M., Kirikae T.

Antimicrob. Agents Chemother. 52:4194-4197(2008) · UniProtKB (2)

1 to 25 of 42  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again